Deregulated microRNA species in the plasma and placenta of patients with preeclampsia

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 527-534

  Yang, Sheng ^a   Li, Hailing ^b   Ge, Qinyu ^b   Guo, Li ^a   Chen, Feng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

microRNA; MicroRNA gene cluster family; Preeclampsia

Indexed keywords

MCROIRNA 518 3P; MICRORNA; MICRORNA 126; MICRORNA 130A; MICRORNA 135B; MICRORNA 142 3P; MICRORNA 149; MICRORNA 16; MICRORNA 188 5P; MICRORNA 18A; MICRORNA 18B; MICRORNA 203; MICRORNA 205; MICRORNA 224; MICRORNA 27A; MICRORNA 29A; MICRORNA 301A; MICRORNA 517C; MICRORNA 518E; MICRORNA 519D; MICRORNA 93; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CLINICAL ARTICLE; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; MALE; MULTIGENE FAMILY; PATHOGENESIS; PLACENTA; PLASMA; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; RNA SEQUENCE; SEQUENCE ANALYSIS; BIOSYNTHESIS; BLOOD; GENETICS; METABOLISM; PATHOLOGY;

ADULT; BIOMARKERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER;

EID: 84926646770     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3414     Document Type: Article

References (41)

1. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K and Williams MA: Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 204: e12-e21, 2011.
2. Redman CW and Sargent IL: Latest advances in understanding preeclampsia. Science 308: 1592-1594, 2005.
3. Grill S, Rusterholz C, Zanetti-Dällenbach R, et al: Potential markers of preeclampsia - a review. Reprod Biol Endocrinol 7: 70, 2009.
4. Roberts JM and Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet 357: 53-56, 2001.
5. Broughton Pipkin F and Roberts JM: Hypertension in pregnancy. J Hum Hypertens 14: 705-724, 2000.
6. Huppertz B: Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51: 970-975, 2008.
7. Scioscia M, Gumaa K, Kunjara S, et al: Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J Clin Endocrinol Metab 91: 709-717, 2006.
8. Yi C, Wang Q, Wang L, et al: MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31: 4421-4433, 2012.
9. Yang Q, Lu J, Wang S, Li H, Ge Q and Lu Z: Application of next-generation sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta 412: 2167-2173, 2011.
10. Salim H, Akbar NS, Zong D, et al: miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br J Cancer 107: 1361-1373, 2012.
11. Guo L, Yang Q, Lu J, et al: A comprehensive survey of miRNA repertoire and 3' addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing. PLoS One 6: e21072, 2011.
12. Yi R, Qin Y, Macara IG and Cullen BR: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016, 2003.
13. Lund E, Güttinger S, Calado A, Dahlberg JE and Kutay U: Nuclear export of microRNA precursors. Science 303: 95-98, 2004.
14. Schwarz DS, Tomari Y and Zamore PD: The RNA-induced silencing complex is a Mg2+-dependent endonuclease. Curr Biol 14: 787-791, 2004.
15. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
16. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
17. Kotlabova K, Doucha J and Hromadnikova I: Placental-specific microRNA in maternal circulation - identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 89: 185-191, 2011.
18. Guo L, Zhao Y, Yang S, Cai M, Wu Q and Chen F: Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer. Mol Biol Rep 40: 2175-2186, 2013.
19. Zhang Y, Diao Z, Su L, et al: MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol 202: e1-e7, 2010.
20. Hu Y, Li P, Hao S, Liu L, Zhao J and Hou Y: Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47: 923-929, 2009.
21. Pineles BL, Romero R, Montenegro D, et al: Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196: e1-e6, 2007.
22. Zhu XM, Han T, Sargent IL, Yin GW and Yao YQ: Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200: e1-e7, 2009.
23. Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158, 2008.
24. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
25. John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human microRNA targets. PLoS Biol 2: e363, 2004.
26. Hsu SD, Lin FM, Wu WY, et al: miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-D169, 2011.
27. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27: 29-34, 1999.
28. Ashburner M, Ball CA, Blake JA, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
29. Kosaka N, Iguchi H and Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092, 2010.
30. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT and Sadovsky Y: The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31: 781-784, 2010.
31. Lázár L, Nagy B, Molvarec A, Szarka A and Rigó J Jr: Role of hsa-miR-325 in the etiopathology of preeclampsia. Mol Med Rep 6: 597-600, 2012.
32. Fish JE, Santoro MM, Morton SU, et al: miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284, 2008.
33. Wang S, Aurora AB, Johnson BA, et al: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271, 2008.
34. Gellhaus A, Schmidt M, Dunk C, Lye SJ and Winterhager E: The circulating proangiogenic factors CYR61 (CCN1) and NOV (CCN3) are significantly decreased in placentae and sera of preeclamptic patients. Reprod Sci 14 (8 Suppl): 46-52, 2007.
35. Morales Prieto DM and Markert UR: MicroRNAs in pregnancy. J Reprod Immunol 88: 106-111, 2011.
36. Mouillet JF, Chu T, Nelson DM, Mishima T and Sadovsky Y: MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 24: 2030-2039, 2010.
37. Maccani MA, Padbury JF and Marsit CJ: miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS One 6: e21210, 2011.
38. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG and Myatt L: MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33: 816-823, 2012.
39. Eremina V and Quaggin SE: The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens 13: 9-15, 2004.
40. Tsatsaris V, Goffin F, Munaut C, et al: Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88: 5555-5563, 2003.
41. Cudmore MJ, Ahmad S, Sissaoui S, et al: Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. Eur Heart J 33: 1150-1158, 2012.